标准普尔/澳交所200指数周三上涨0.2%,至8330点左右,延续了前一交易日的涨幅,医疗保健股领涨。投资者还为美联储预期的降息做好了准备,密切关注未来宽松政策的任何信号。在国内,人们的注意力转向了即将公布的澳大利亚储备银行上次会议纪要,该行将利率维持在4.35%不变。此后,在经济活动放缓的迹象下,市场参与者提出了对澳大利亚储备银行首次降息的预期。医疗保健板块大幅上涨,CSL Ltd(上涨1.1%)、Pro Medicus(上涨1.4%)和Clarity Pharmaceuticals(上涨16.1%)领涨。其他指数权重股也上涨,包括必和必拓集团(上涨0.5%)、Wesfarmers(上涨0.4%)和西太平洋银行(上涨0.6%)。
The S&P/ASX 200 Index rose by 0.2% to around 8,330 on Wednesday, extending the previous session’s gains, with healthcare stocks leading the charge. Investors also braced for an anticipated interest rate cut from the US Federal Reserve, closely watching for any signals on future easing. Domestically, attention turned to the upcoming release of minutes from the Reserve Bank of Australia's last meeting, where it kept rates unchanged at 4.35%. Market participants have since brought forward expectations for the first RBA rate cut, amid signs of slowing economic activity. The healthcare sector saw notable gains, driven by CSL Ltd (up 1.1%), Pro Medicus (up 1.4%), and Clarity Pharmaceuticals (up 16.1%). Other index heavyweights also advanced, including BHP Group (up 0.5%), Wesfarmers (up 0.4%), and Westpac Banking (up 0.6%).